9,10-dimethyl-1,2-benzanthracene has been researched along with maxacalcitol in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ashino-Fuse, H; Iwaguchi, T; Oikawa, T; Shimamura, M; Tominaga, T; Yoshida, Y | 1 |
1 other study(ies) available for 9,10-dimethyl-1,2-benzanthracene and maxacalcitol
Article | Year |
---|---|
Antitumor effect of 22-oxa-1 alpha,25-dihydroxyvitamin D3, a potent angiogenesis inhibitor, on rat mammary tumors induced by 7,12-dimethylbenz[a]anthracene.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Body Weight; Calcitriol; Calcium; Female; Mammary Neoplasms, Experimental; Neovascularization, Pathologic; Organ Size; Rats; Rats, Inbred Strains | 1991 |